Therapies of Early, Advanced, and Late Onset Forms of Axial Spondyloarthritis, and the Need for Treat to Target Strategies


Akkoc N., CAN G., D'Angelo S., Padula A., Olivieri I.

CURRENT RHEUMATOLOGY REPORTS, vol.19, no.2, 2017 (SCI-Expanded) identifier identifier identifier

  • Publication Type: Article / Article
  • Volume: 19 Issue: 2
  • Publication Date: 2017
  • Doi Number: 10.1007/s11926-017-0633-0
  • Journal Name: CURRENT RHEUMATOLOGY REPORTS
  • Journal Indexes: Science Citation Index Expanded (SCI-EXPANDED), Scopus
  • Keywords: Axial spondyloarthritis, Non-radiographic axial spondyloarthritis, Ankylosing spondylitis, Treatment, Treat to target, NSAIDs, DMARDs, TNF inhibitors, Secukinumab, IL-17A, ACTIVE ANKYLOSING-SPONDYLITIS, METHYLPREDNISOLONE PULSE THERAPY, NONSTEROIDAL ANTIINFLAMMATORY DRUGS, REDUCES SPINAL INFLAMMATION, PROOF-OF-CONCEPT, OPEN-LABEL TRIAL, DOUBLE-BLIND, PSORIATIC-ARTHRITIS, INTRAVENOUS METHYLPREDNISOLONE, DISEASE-ACTIVITY
  • Dokuz Eylül University Affiliated: Yes

Abstract

Purpose of Review This study aims to provide an update on current status of pharmacological therapies in early and advanced stages of axial spondyloarthritis (axSpA), as well as its late onset forms, and to discuss the need for treat to target strategies in this entity.